Two of them, carriers for an additive MTHFR mutation with increased homocysteine level, presenting for bilateral extensive lower extremity venous thrombosis and severe PE, were extremely resistant to anticoagulant therapy and required IVC filter insertion, aggressive, and prolonged anticoagulation. Here, MTHFR is linked to Venous thrombosis.